The epidemiology of blood component transfusion in Catalonia, Northeastern Spain

Transfusion

Volumn 51, Issue 1, 2011, Pages 105-116

  Bosch, M Alba ^a,b,c,d   Contreras, Enric ^a,b,c,d   Madoz, Pedro ^a,b,c,d   Ortiz, Pilar ^a,b,c,d   Pereira, Arturo ^a,b,c,d   Pujol, M Mar ^a,b,c,d  

^a BANC DE SANG I TEIXITS   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEMOLYTIC ANEMIA; ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; BLOOD COMPONENT THERAPY; CANCER PATIENT; CLINICAL PROTOCOL; CROSS-SECTIONAL STUDY; DEMOGRAPHY; EPIDEMIOLOGICAL DATA; ERYTHROCYTE TRANSFUSION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEALTH SURVEY; HEART VALVE SURGERY; HEMATOLOGIC MALIGNANCY; HEMOLYTIC ANEMIA; HOSPITAL; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LEG REVASCULARIZATION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTICENTER STUDY; MYELODYSPLASTIC SYNDROME; ONCOLOGY; ORTHOPEDIC SURGERY; PLASMA TRANSFUSION; PLASMAPHERESIS; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; RECIPIENT; SPAIN; THROMBOCYTE TRANSFUSION; TREATMENT INDICATION;

AGED; BLOOD COMPONENT TRANSFUSION; CROSS-SECTIONAL STUDIES; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; MALE; PLATELET TRANSFUSION; SPAIN;

EID: 78651361525     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02785.x     Document Type: Article

References (35)

1. Vamvakas EC,. Epidemiology of red blood cell utilization. Transfus Med Rev 1996; 10: 44-61.
2. Vamvakas EC,. Epidemiology of blood transfusion and forecasts of the demand for blood. In:, Vamvakas EC, editor. Evidence-based practice of transfusion medicine. Bethesda (MD): AABB Press; 2001. p. 177-99.
3. Biggin K, Warner P, Prescott R, McClelland B,. A review of methods used in comprehensive, descriptive studies that relate red blood cell transfusion to clinical data. Transfusion 2010; 50: 711-8.
4. Hillyer CD, Blumberg N, Glynn SA,. Ness PM for the members of the NHLBI Working Group in Transfusion Epidemiology and Outcomes Research. Transfusion recipient epidemiology and outcomes research: possibilities for the future. Transfusion 2008; 48: 1530-7.
5. Vamvakas EC, Goldstein R,. Four-year survival of transfusion recipients identify by hepatitis C lookback. Transfusion 2002; 42: 691-7.
6. Wallis JP, Wells AW, Chapman CF,. Long-term survival after blood transfusion: a population based study in the North of England. Transfusion 2004; 44: 1025-32.
7. Vamvakas EC, Taswell HF,. Epidemiology of blood transfusion. Transfusion 1994; 34: 464-70.
8. Mathoulin-Pélissier S, Salmi LR, Verret C, Demoures B,. Blood transfusion in a random sample of hospitals in France. Transfusion 2000; 40: 1140-6.
9. Titlestad K, Georgsen J, Jorgensen J, Kristensen T,. Monitoring transfusion practices at two university hospitals. Vox Sang 2001; 80: 40-7.
10. Wells AW, Mounter PJ, Chapman CE, Stainsby D, Wallis JP,. Where does blood go? Prospective observational study of red cell transfusion in north England. BMJ 2002; 325: 803-6.
11. Wallis JP, Wells AW, Chapman CE,. Changing indications for red cell transfusion from 2000 to 2004 in the North of England. Transfus Med 2006; 16: 411-7.
12. Quaranta JF, Berthier F, Courbil R, Courtois F, Chenais F, Waller C, Leconte des Floris MF, Andreu G, Fontaine O, Le Níger C, Puntous M, Mercadier A, Nguyen L, Pélissier E, Gondrexon G, Staccini P,. Qui sont les receveurs de produits sanguins labiles (PSL)? Une étude nationale multicentriqueâun jour donné. Ãtablissement de transfusion sanguine (ETS)âétablissements de santé (ES). Transfus Clin Biol 2009; 16: 21-9.
13. Zimmermann R, Buscher M, Linhardt C, Handtrack D, Zingsem J, Weisbach V, Eckstein R,. A survey of blood component use in a German university hospital. Transfusion 1997; 37: 1075-83.
14. Chiavetta JA, Herst R, Freedman J, Axcell TJ, Wall AJ, van Rooy SC,. A survey of red cell use in 45 hospitals in central Ontario, Canada. Transfusion 1996; 36: 699-706.
15. Lim YA, Lee WG, Cho SR, Hyun BH,. A study of blood usage by diagnoses in a Korean university hospital. Vox Sang 2004; 86: 54-61.
16. Kelley JR, Duggan JM,. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003; 56: 1-9.
17. Chuang SC, La Vecchia C, Boffetta P,. Liver cancerâdescriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett 2009; 286: 9-14.
18. Meads C, Cummins C, Jolly K, Stevens A, Burls A, Hyde C,. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review. Health Technol Assess 2000; 4: 1-153.
19. Krone RJ, Shaw RE, Klein LW, Blankenship JC, Weintraub WS,. Ad hoc percutaneous coronary interventions in patients with stable coronary artery diseaseâA study of prevalence, safety, and variation in use from the American College of Cardiology National Cardiovascular Data Registry (ACC-NCDRÂ). Catheter Cardiovasc Interv 2006; 68: 696-703.
20. Cobain TJ, Vamvakas EC, Wells A, Titlestad K,. A survey of the demographics of blood use. Transfus Med 2007; 17: 1-15.
21. Van der Poel CL, Janssen MP,. The collection, testing and use of blood and blood products in Europe 2003âFinal report. Working document of the European Committee on Blood Transfusion. Strasbourg, France: Council of Europe Publishing; 2003.
22. Voelker R,. Common drugs can harm elderly patients. JAMA 2009; 302: 614-5.
23. McCarthy DM,. GI bleeding: problems that persist. Gastrointest Endosc 2009; 70: 225-8.
24. Patel KV,. Epidemiology of anemia in older adults. Semin Hematol 2008; 45: 210-7.
25. Sihler KC, Napolitano LM,. Massive transfusion: new insights. Chest 2009; 136: 1654-67.
26. Riskin DJ, Tsai TC, Riskin L, Hernandez-Boussard T, Purtill M, Maggio PM, Spain DA, Brundage SI,. Massive transfusion protocolsâthe role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg 2009; 209: 198-205.
27. Laine E, Steadman R, Calhoun L, Blackall D, Levin P, Braunfeld M, Nourmand H, Neelakanta G, Ting L, Gornbein J, Busuttil R, Petz L,. Comparison of RBCs and FFP with whole blood during liver transplant surgery. Transfusion 2003; 43: 322-7.
28. Repine TB, Perkins JG, Kauvar DS, Blackborne L,. The use of fresh whole blood in massive transfusion. J Trauma 2006; 60: S59-69.
29. Palo R, Capraro L, Hovilehto S, Koivuranta M, Krusius T, Loponen E, Mäntykoski R, Pentti J, Pitkänen O, Raitakari M, Rimpiläinen J, Salmenperä M, Salo H, Mäki T,. Population-based audit of fresh-frozen plasma transfusion practices. Transfusion 2006; 46: 1921-5.
30. Prowse C,. Properties of pathogen-inactivated plasma components. Transfus Med Rev 2009; 23: 124-33.
31. Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G, Barbui T, Mandelli F, Sirchia G,. The threshold for prophylactic platelet transfusions in adults with acute myeloid leucemia. Gruppo italiano malattie ematologiche maligne dell'adulto. N Engl J Med 1997; 337: 1870-5.
32. Norol F, Bierling P, Roudot-Thoraval F, Ferrer Le Coeur F, Rieux C, Lavaux A, Kuentz M, Duedari N,. Platelet transfusion: a dose-response study. Blood 1998; 92: 1448-53.
33. Diedrich B, Ringdén O, Watz E, Shanwell A,. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients. Vox Sang 2009; 97: 254-9.
34. Currie CJ, Patel TC, McEwan P, Dixon S,. Evaluation of the future supply and demand for blood products in the United Kingdom National Health Service. Transfus Med 2004; 14: 19-24.
35. Ali A, Auvinen MK, Rautonen J,. The aging population poses a global challenge for blood services. Transfusion 2010; 50: 584-8.